tert-Butyl 2,2-dimethyl-3-oxo-4-propylpiperazine-1-carboxylate

Catalog No.: 
ACOCZQ555
CAS No.: 
1803604-77-4
Molecular Formula: 
C14H26N2O3
Molecular Weight: 
270.37
tert-Butyl 2,2-dimethyl-3-oxo-4-propylpiperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$245.00InquiryInquiry
100mg95%$358.00InquiryInquiry
250mg95%$504.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2,2-dimethyl-3-oxo-4-propylpiperazine-1-carboxylate
IUPAC Nametert-butyl 2,2-dimethyl-3-oxo-4-propylpiperazine-1-carboxylate
MDL No.MFCD27500858
Molecular FormulaC14H26N2O3
Molecular Weight270.37
SMILESO=C(N1C(C)(C)C(N(CCC)CC1)=O)OC(C)(C)C
InChI KeyPZIHZFOSOMBJBG-UHFFFAOYSA-N
Synonym1-Piperazinecarboxylic acid, 2,2-dimethyl-3-oxo-4-propyl-, 1,1-dimethylethyl ester;tert-Butyl 2,2-dimethyl-3-oxo-4-propylpiperazine-1-carboxylate
CAS No.1803604-77-4

Synthetic Route by SureRoute

1. ACOCZQ555 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCYUN129 route compound structure diagram
    ACCYUN1291104383-06-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCZQ555 route product structure diagram
    ACOCZQ5551803604-77-4
Inquiry

2. ACOCZQ555 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCYUN129 route compound structure diagram
    ACCYUN1291104383-06-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCZQ555 route product structure diagram
    ACOCZQ5551803604-77-4
Inquiry

3. ACOCZQ555 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCZQ555 route product structure diagram
    ACOCZQ5551803604-77-4
Inquiry

Comments (0)